SOURCES SOUGHT
Q -- biodefense diagonostics & surveillance RFI
- Notice Date
- 8/30/2005
- Notice Type
- Sources Sought
- NAICS
- 541710
— Research and Development in the Physical, Engineering, and Life Sciences
- Contracting Office
- Department of the Air Force, Air Force Materiel Command, HSW - 311 Human Systems Wing, 311th HSW/PK 8150 Aeromedical Road, Brooks AFB, TX, 78235-5123
- ZIP Code
- 78235-5123
- Solicitation Number
- Reference-Number-PWRFI001
- Response Due
- 9/7/2005
- Archive Date
- 9/22/2005
- Description
- ATTENTION: PLEASE ADDRESS ALL CORRESPONDENCE TO MR. LAWRENCE MITCHELL OR 1LT MAURICE EDMONDSON: lawrence.mitchell@pentagon.af.mil OR maurice.edmondson@brooks.af.mil Current Concepts of Operation (CONOPS), technologies, and Tactics, Techniques and Procedures (TTP) all lack required integration of information to give Combatant Commander near real time status of a biological event. This system of systems will address the shortfall with a comprehensive diagnostic and informatics surveillance system, utilizing ?state of the art? technology, identifying both natural and hostile biological pathogens, near ?real-time?. This announcement covers a systems technology which is a transformation dual use approach for operational medicine and biodefense, designed to rapidly detect and identify a wide range of pathogens. It is intended to overcome two diagnostic challenges to discriminate between diverse pathogens that present similar to flu-like symptoms; and screen rapidly, accurately and simultaneiously across multiple 20-100+ candidate pathogens. This technology will use sophisticated, molecular biology procedures, bio-informatics, and connectivity to provide commanders at all levels the information needed to make time-critical decisions. Ultimately this situational awareness provides a high likelihood that correct diagnostic decision will be made, even prior to the onset of symptoms. Interested contractors are requested to forward a talking paper, not more than two (2) pages in length together with candidate product information sheets for diagnostics and surveillance, not later than 7 September, 2005 to the following: Advanced Diagnostics Lab, Attention Mr. Lawrence Mitchell, 5201 Leesburg Pike, Suite 1401, Falls Church, Virginia 22041. lawrence.mitchell@pentagon.af.mil. All submissions should be sent electronically, even if additional copies or fact sheets are mailed separately. The offeror's response needs to provide at a minimum, all areas in the criteria section below: It is the Government's intent to ultimately contract with a viable company for the purpose of developing an advanced diagnostics system. The solicitation is issued without restrictions and is intended only to invite participation. It is not intended as an invitation for proposals. The importance of rapid detection of biological pathogens for both common and bio-warfare agents is well documented, embedded in several Joint Requirement documents, including CJCS Force Health Protection, Joint War fighting S&T Plan, 2003, and most recently Deputy Secretary of Defense Memorandum for Joint Chiefs of Staff, dated 20 Jan, 2004, requirement the military health system to develop the next generation of ?integrated early warning health protection systems?. COCOMs need the ability to detect biological events/attacks in near real time to project (warn, treat, and respond) forward forces, garrisoned troops, and forces at embarkation, and debarkation. This technology will leverage RDT&E for a Level 3 platform (clinics or Expeditionary Medical Support (EMEDS)) components to improve capabilities of a Level 5 (medical treatment facilities such as large hospitals with clinical and medial research laboratory facilities) and highly trained personnel. This platform level represents initial baseline capabilities for the installation at the Advanced Diagnostics lab, Lackland AFB (prototype testing and demonstration). The offeror/contractor will be asked to address in writing how the company's technology is capable of meeting the following provisions: 1. Diagnostics are capable of detecting 20 pathogens or more within four (4) or less hours at a total cost not to exceed $75. 2. Detection uses diagnostics technology that is FDA approved 3. Demonstrate the capacity to perform biosurveillance using a multiplex detection process of clinical specimens for up to 100 pathogens in four (4) hours or less 4. Diagnostics capability will test upper respiratory infections utilizing throat swabs, nasal washings, and blood specimens After reviewing the offerors' technology solution, selected contractors will be asked to participate in a demonstration/presentation of their technology at the Westin Hotel in San Antonio, Texas, on September 26-28, 2005. Final date of presentations will be determined after selection of candidates is approved. Candidates will be notified of their participation electronically not later than 9 September, 2005. Format for the presentations of candidate vendors will be provided in detail following selection.
- Place of Performance
- Address: San Antonio, TX
- Country: USA
- Country: USA
- Record
- SN00882595-W 20050901/050830212128 (fbodaily.com)
- Source
-
FedBizOpps.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |